ABC Heart Fail Cardiomyop 2022; 2(4): 331-332

Cardio-Oncology: Far Beyond Doxorubicin and the Tip of the Iceberg!

Wolney de Andrade Martins , Ariane Vieira Scarlatelli Macedo , Lidia Ana Zytynski Moura

DOI: 10.36660/abchf.20230003

Cardio-oncology is a new field of work and research on the adverse cardiovascular effects of cancer treatment, comorbidities and clinical conditions in cancer patients, and cardiovascular tumors. It has a wide spectrum ranging from arterial hypertension, arrhythmias, coronary and thromboembolic diseases to ventricular dysfunction, among others. In this special issue of ABC Heart Failure, we will focus on myocardial lesions, and consequently cardiomyopathies, ventricular dysfunction and heart failure (HF).

The Department of HF of the Brazilian Society of Cardiology has embraced Cardio-oncology since its beginning, by opening space for scientific discussion in its events and thematic area for abstract submissions, and now by offering this special issue addressing the main manifestations of endomyocardial/pericardial diseases and HF in cancer patients.

[…]